
Melissa Jean Perreira
Examiner (ID: 10386, Phone: (571)272-1354 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1065 |
| Issued Applications | 491 |
| Pending Applications | 87 |
| Abandoned Applications | 511 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18800081
[patent_doc_number] => 11833227
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-05
[patent_title] => Methods for preserving a subject and using imaging contrast agents
[patent_app_type] => utility
[patent_app_number] => 16/888114
[patent_app_country] => US
[patent_app_date] => 2020-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 27
[patent_no_of_words] => 12300
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16888114
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/888114 | Methods for preserving a subject and using imaging contrast agents | May 28, 2020 | Issued |
Array
(
[id] => 16312244
[patent_doc_number] => 20200290982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => METAL/RADIOMETAL-LABELED PSMA INHIBITORS FOR PSMA-TARGETED IMAGING AND RADIOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 16/887754
[patent_app_country] => US
[patent_app_date] => 2020-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26237
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16887754
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/887754 | METAL/RADIOMETAL-LABELED PSMA INHIBITORS FOR PSMA-TARGETED IMAGING AND RADIOTHERAPY | May 28, 2020 | Abandoned |
Array
(
[id] => 16466834
[patent_doc_number] => 20200368371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-26
[patent_title] => DYE-PROTEIN COMPLEX FOR NIR II AND PHOTOACOUSTIC IMAGING
[patent_app_type] => utility
[patent_app_number] => 16/879851
[patent_app_country] => US
[patent_app_date] => 2020-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8314
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16879851
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/879851 | DYE-PROTEIN COMPLEX FOR NIR II AND PHOTOACOUSTIC IMAGING | May 20, 2020 | Abandoned |
Array
(
[id] => 17889837
[patent_doc_number] => 11452784
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-27
[patent_title] => Size-varying bubble complex and method of preparing the same
[patent_app_type] => utility
[patent_app_number] => 16/876606
[patent_app_country] => US
[patent_app_date] => 2020-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5671
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16876606
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/876606 | Size-varying bubble complex and method of preparing the same | May 17, 2020 | Issued |
Array
(
[id] => 18059346
[patent_doc_number] => 20220390432
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => METHODS OF CHARACTERIZING AND UTILIZING AGENT-CONDENSATE INTERACTIONS
[patent_app_type] => utility
[patent_app_number] => 17/611560
[patent_app_country] => US
[patent_app_date] => 2020-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50264
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17611560
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/611560 | METHODS OF CHARACTERIZING AND UTILIZING AGENT-CONDENSATE INTERACTIONS | May 14, 2020 | Pending |
Array
(
[id] => 17733424
[patent_doc_number] => 20220218883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => Implantable Device Coated by a Self-Assembled Monolayer and Therapeutic Agent
[patent_app_type] => utility
[patent_app_number] => 17/605846
[patent_app_country] => US
[patent_app_date] => 2020-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11961
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17605846
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/605846 | Implantable Device Coated by a Self-Assembled Monolayer and Therapeutic Agent | Apr 23, 2020 | Pending |
Array
(
[id] => 17883063
[patent_doc_number] => 20220298540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-22
[patent_title] => METHOD AND REAGENTS FOR DETECTING LUCIFERASE ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 17/633843
[patent_app_country] => US
[patent_app_date] => 2020-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6725
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17633843
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/633843 | METHOD AND REAGENTS FOR DETECTING LUCIFERASE ACTIVITY | Apr 13, 2020 | Abandoned |
Array
(
[id] => 17513668
[patent_doc_number] => 11292798
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-05
[patent_title] => Merocyanine-based compound and biomolecular labeling dye, kit and contrast agent composition comprising same
[patent_app_type] => utility
[patent_app_number] => 16/848586
[patent_app_country] => US
[patent_app_date] => 2020-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 7700
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 562
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16848586
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/848586 | Merocyanine-based compound and biomolecular labeling dye, kit and contrast agent composition comprising same | Apr 13, 2020 | Issued |
Array
(
[id] => 16375157
[patent_doc_number] => 20200323999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => SALINE NANODROPLETS FOR RADIO-FREQUENCY-ACOUSTIC MOLECULAR IMAGING
[patent_app_type] => utility
[patent_app_number] => 16/831899
[patent_app_country] => US
[patent_app_date] => 2020-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15055
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16831899
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/831899 | SALINE NANODROPLETS FOR RADIO-FREQUENCY-ACOUSTIC MOLECULAR IMAGING | Mar 26, 2020 | Abandoned |
Array
(
[id] => 16523847
[patent_doc_number] => 20200397927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/828119
[patent_app_country] => US
[patent_app_date] => 2020-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69350
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16828119
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/828119 | COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS | Mar 23, 2020 | Abandoned |
Array
(
[id] => 18978873
[patent_doc_number] => 11904027
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-20
[patent_title] => Stable, concentrated radionuclide complex solutions
[patent_app_type] => utility
[patent_app_number] => 16/827606
[patent_app_country] => US
[patent_app_date] => 2020-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14064
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 185
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16827606
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/827606 | Stable, concentrated radionuclide complex solutions | Mar 22, 2020 | Issued |
Array
(
[id] => 16189414
[patent_doc_number] => 20200230263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => NOVEL DEUTERIUM SUBSTITUTED POSITRON EMISSION TOMOGRAPHY (PET) IMAGING AGENTS AND THEIR PHARMACOLOGICAL APPLICATION
[patent_app_type] => utility
[patent_app_number] => 16/824139
[patent_app_country] => US
[patent_app_date] => 2020-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21992
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16824139
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/824139 | Deuterium substituted positron emission tomography (PET) imaging agents and their pharmacological application | Mar 18, 2020 | Issued |
Array
(
[id] => 16862721
[patent_doc_number] => 11021450
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-01
[patent_title] => PSMA targeted fluorescent agents for image guided surgery
[patent_app_type] => utility
[patent_app_number] => 16/820052
[patent_app_country] => US
[patent_app_date] => 2020-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 50
[patent_no_of_words] => 23394
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 179
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16820052
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/820052 | PSMA targeted fluorescent agents for image guided surgery | Mar 15, 2020 | Issued |
Array
(
[id] => 19490591
[patent_doc_number] => 12109276
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-08
[patent_title] => Near-infrared dyes and conjugates for targeting tumors
[patent_app_type] => utility
[patent_app_number] => 16/816118
[patent_app_country] => US
[patent_app_date] => 2020-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 17
[patent_no_of_words] => 5631
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16816118
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/816118 | Near-infrared dyes and conjugates for targeting tumors | Mar 10, 2020 | Issued |
Array
(
[id] => 16052957
[patent_doc_number] => 20200188333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => ABUSE-PROOFED DOSAGE FORM
[patent_app_type] => utility
[patent_app_number] => 16/797016
[patent_app_country] => US
[patent_app_date] => 2020-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9514
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -50
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16797016
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/797016 | ABUSE-PROOFED DOSAGE FORM | Feb 20, 2020 | Abandoned |
Array
(
[id] => 16153641
[patent_doc_number] => 20200215053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => ABUSE-PROOFED DOSAGE FORM
[patent_app_type] => utility
[patent_app_number] => 16/797055
[patent_app_country] => US
[patent_app_date] => 2020-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16043
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16797055
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/797055 | ABUSE-PROOFED DOSAGE FORM | Feb 20, 2020 | Abandoned |
Array
(
[id] => 15928165
[patent_doc_number] => 20200155716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => RADIOACTIVE COMPOSITIONS AND METHODS FOR THEIR THERAPEUTIC USE
[patent_app_type] => utility
[patent_app_number] => 16/773398
[patent_app_country] => US
[patent_app_date] => 2020-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21471
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16773398
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/773398 | Radioactive compositions and methods for their therapeutic use | Jan 26, 2020 | Issued |
Array
(
[id] => 16009343
[patent_doc_number] => 20200179514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => PHTHALOCYANINE PROBES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/751850
[patent_app_country] => US
[patent_app_date] => 2020-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15295
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16751850
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/751850 | PHTHALOCYANINE PROBES AND USES THEREOF | Jan 23, 2020 | Abandoned |
Array
(
[id] => 17306349
[patent_doc_number] => 11207432
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-28
[patent_title] => Substituted organofluoroborates as imaging agents
[patent_app_type] => utility
[patent_app_number] => 16/746458
[patent_app_country] => US
[patent_app_date] => 2020-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 45
[patent_no_of_words] => 33668
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1648
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16746458
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/746458 | Substituted organofluoroborates as imaging agents | Jan 16, 2020 | Issued |
Array
(
[id] => 17505116
[patent_doc_number] => 20220098218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => COMPLEX OF GADOLINIUM AND A CHELATING LIGAND DERIVED OF A DIASTEREOISOMERICALLY ENRICHED PCTA AND SYNTHESIS METHOD
[patent_app_type] => utility
[patent_app_number] => 17/423589
[patent_app_country] => US
[patent_app_date] => 2020-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12375
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17423589
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/423589 | COMPLEX OF GADOLINIUM AND A CHELATING LIGAND DERIVED OF A DIASTEREOISOMERICALLY ENRICHED PCTA AND SYNTHESIS METHOD | Jan 16, 2020 | Abandoned |